COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of May 4, 2021
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.
Diabetes Management in CKD: 10 Top Takeaways from KDIGO 2020
The 2020 Kidney Disease: Improving Global Outcomes Clinical Practice Guideline integrates new treatments and practices with existing management strategies for CKD patients with diabetes.
ACP: DOAC Dos and Don'ts Primer with Stephan Moll, MD
ACP 2021: Dr Stephan Moll covers the basics of DOAC duration for VTE, use of anticoagulation in special populations, and perioperative use of DOACs
FDA Approves Dapagliflozin to Treat Chronic Kidney Disease in Adults at Risk of Progression, Regardless of Diabetes Status
Dapagliflozin is the first SGLT-2 inhibitor to receive FDA approval for the treatment of CKD, regardless of diabetes status.
ACP: Lessons Learned during COVID-19 Pandemic
CDC Director Rochelle Walensky, MD MPH, was a featured presenter at the recent ACP Internal Medicine Meeting 2021: Virtual Experience, where she spoke about lessons learned during COVID-19.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of May 3, 2021
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
ACP: ASCVD Risk Estimation for Primary Prevention with Donald Lloyd-Jones, MD, ScM
"Risk estimators do not prescribe a drug," says Dr Lloyd-Jones. They are tools to help make the decision to prescribe the drug. He explains how to use them in primary care.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 30, 2021
Primary Care COVID-19 Check-up: Physicians Remain Steady, but Challenges Mount
Primary care practices are keeping pace a year into the pandemic but face rising challenges—from mental exhaustion to lack of vaccine supplies, according to a national primary care survey.
ACP: Clyde Yancy, MD, MSc Reviews Advances in Heart Failure Research and Treatment
ACP: Clyde W Yancy, MD, gave a comprehensive update on a year's worth of pivotal science in treatment of heart failure. Here are the highlights.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 29, 2021
Fauci: Widespread COVID-19 Vaccination, Precautions Key to Ending Pandemic
The NIAID head said the timing of the end of the pandemic is really up to the public.
Early Intervention in Weight Management: Treating Pre-Obesity
Research shows that increased risk of chronic disease and mortality begins below a BMI classified as obesity. The earlier we intervene with at-risk patients, the greater the chance for success.
Bariatric Surgery Associated with Reduced Mortality in Patient with T2D, Obesity
Authors of a new study say their findings suggest bariatric surgery should be considered first-line treatment for the management of obesity in patients with type 2 diabetes.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 28, 2021
CDC: Two-thirds of Patients with Mild COVID-19 Get New Diagnosis within 6 Months
More than two-thirds of a large group of patients not hospitalized for COVID-19 made at least 1 outpatient visit and left with a new diagnosis within 6 months of their first diagnosis.
Should the CDC 2016 Opioid Prescribing Guideline be Revoked? Health Care Providers, Patients Say “Yes” in New Survey
The large survey found that 9 out of 10 patients believe their pain levels and quality of life have worsened under the CDC's 2016 opioid prescribing guideline.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 27, 2021
NAFLD & NASH Treatment in Primary Care: 8 Questions based on AASLD Guidance
Weight loss for patients with NAFLD is the key to improvement of histopathologic features. Find out what else you know about treatment of NAFLD/NASH with 8 guidance-based questions.
Study: GLP-1 Receptor Agonist Therapy Reduces Asthma Exacerbations in Adults with Asthma, T2D
New findings suggest that patients with asthma and type 2 diabetes who use GLP-1 RAs for diabetes treatment intensification have fewer asthma exacerbations compared to other diabetes drugs.
